PH19017A - Preparation of 1,2-dihydro-6-(lower alkyl) 2-oxo-5-(pyridinyl)-nicotinonitriles - Google Patents

Preparation of 1,2-dihydro-6-(lower alkyl) 2-oxo-5-(pyridinyl)-nicotinonitriles

Info

Publication number
PH19017A
PH19017A PH28936A PH28936A PH19017A PH 19017 A PH19017 A PH 19017A PH 28936 A PH28936 A PH 28936A PH 28936 A PH28936 A PH 28936A PH 19017 A PH19017 A PH 19017A
Authority
PH
Philippines
Prior art keywords
nicotinonitriles
pyridinyl
dihydro
oxo
preparation
Prior art date
Application number
PH28936A
Other languages
English (en)
Inventor
Baldev Singh
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of PH19017A publication Critical patent/PH19017A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH28936A 1982-05-24 1983-05-19 Preparation of 1,2-dihydro-6-(lower alkyl) 2-oxo-5-(pyridinyl)-nicotinonitriles PH19017A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/381,062 US4413127A (en) 1982-05-24 1982-05-24 Preparation of 1,2-dihydro-6-(lower alkyl)-2-oxo-5-(pyridinyl)nicotinonitriles

Publications (1)

Publication Number Publication Date
PH19017A true PH19017A (en) 1985-12-03

Family

ID=23503512

Family Applications (1)

Application Number Title Priority Date Filing Date
PH28936A PH19017A (en) 1982-05-24 1983-05-19 Preparation of 1,2-dihydro-6-(lower alkyl) 2-oxo-5-(pyridinyl)-nicotinonitriles

Country Status (7)

Country Link
US (1) US4413127A (ko)
JP (1) JPS5925374A (ko)
CA (1) CA1183138A (ko)
ES (1) ES540882A0 (ko)
MX (1) MX5918A (ko)
PH (1) PH19017A (ko)
ZA (1) ZA833246B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4469871A (en) * 1982-05-24 1984-09-04 Sterling Drug Inc. Process for preparing 2-(lower-alkoxy)-1-(pyridinyl) ethenyl lower-alkyl ketones
EP0200024B1 (de) 1985-04-30 1992-07-01 ARZNEIMITTELWERK DRESDEN GmbH 3-Cyan-pyridine, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
US4681944A (en) * 1985-06-11 1987-07-21 Ippolito Robert M Process for preparing certain 1-lower alkanoyl or benzoyl-4-(lower alkanoyl or benzoyl-methylidene)-1,4-dihydropyridines or acid addition salts thereof
US5204463A (en) * 1989-08-10 1993-04-20 Glaxo Inc. Substituted methoxyphenyl-4,5 dihydro-3(2H)-pridazinones having cardiotonic and beta blocking activities
US5153209A (en) * 1989-09-22 1992-10-06 Glaxo Inc. Pyridone nitriles useful in treating cardiovascular disease
US5051431A (en) * 1989-09-22 1991-09-24 Glaxo Inc. Pyridone nitriles useful in treating cardiovascular disease
US5100892A (en) * 1990-11-13 1992-03-31 Glaxo Inc. Dihydropyridine vasodilator agents
US6118002A (en) * 1999-03-02 2000-09-12 Wyckoff Chemical Company, Inc. Purification of 1,2-dihydro-6-alkyl-2-oxo-5-(pyridinyl)-nicotinonitriles
CN103804288A (zh) * 2012-11-12 2014-05-21 四川新斯顿制药有限责任公司 一种米力农的合成方法
CN103965101B (zh) * 2014-05-21 2016-07-06 合肥久诺医药科技有限公司 一种米力农的制备方法
AU2016218976B2 (en) 2015-02-13 2021-04-01 Cumberland Pharmaceuticals, Inc. Milrinone composition and method for administering same
CN104744357A (zh) * 2015-03-30 2015-07-01 浙江中维药业有限公司 米力农的重结晶提纯方法
CN111377858B (zh) * 2018-12-30 2023-04-07 鲁南制药集团股份有限公司 一种米力农的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2824121A (en) * 1954-11-04 1958-02-18 Kay Fries Chemicals Inc Process for preparation of oxy alkylidene compounds
US4223149A (en) * 1979-07-26 1980-09-16 Sterling Drug Inc. Process for producing 3-cyano-5-(pyridinyl)-2(1H)-pyridinones
US4313951A (en) * 1979-11-26 1982-02-02 Sterling Drug Inc. 3-Substituted-6-(lower-alkyl)-5-(pyridinyl)-2(1H)-pyridinones, their cardiotonic use and intermediates therefor
NZ196573A (en) * 1980-03-28 1984-03-16 Sterling Drug Inc 6-pyrid-(3 or 4)-yl-(1h or 3h)-imidazo (4,5-b)pyridines

Also Published As

Publication number Publication date
JPS5925374A (ja) 1984-02-09
US4413127A (en) 1983-11-01
JPH0127064B2 (ko) 1989-05-26
ES8601896A1 (es) 1985-11-16
ZA833246B (en) 1984-01-25
CA1183138A (en) 1985-02-26
MX5918A (es) 1993-09-01
ES540882A0 (es) 1985-11-16

Similar Documents

Publication Publication Date Title
CS672184A2 (en) Zpusob vyroby 1-heteroaryl-4-((2,5-pyrrolidindion-1-yl)alkyl)piperazinovych derivatu
GB8327018D0 (en) Making of bags
DE3372476D1 (en) Preparation of p-nitrosodiphenylamine
IL68537A (en) Preparation of 26,26,26,27,27,27,-hexafluoro-1,25-dihydroxy-cholesterol
GB8311819D0 (en) Pyridine compounds
DE3378119D1 (en) Preparation of 6a, 10a-trans-hexahydrodibenzopyranones
PH19017A (en) Preparation of 1,2-dihydro-6-(lower alkyl) 2-oxo-5-(pyridinyl)-nicotinonitriles
GB2087383B (en) Preparation of 1,1,1,3,3,-hexafluoropropane-2-ol
GB2094788B (en) Preparation of 2,3-dichloro-5-trichloromethylpyridine
IL69096A0 (en) Preparation of n-phosphonomethyl-glycine
IL70307A (en) Preparation of(trifluoromethyl)pyridines
GB8300598D0 (en) Preparation of 3,3'/3,4' diaminobenzophenones
DE3360040D1 (en) Process for the preparation of 2,3-dichlorobutadiene-1,3
GB8317345D0 (en) Preparation of arylethylamines
GB2094791B (en) Preparation of 1,3,4-thiadiazolones
GB8322800D0 (en) Preparation of 1,2,4,5-tetraalkylbenzenes
DE3361151D1 (en) Process for the preparation of 2,3,5-trimethyl-p-benzoquinone
GB2120656B (en) Preparation of thio-bis-phenols
DE3360784D1 (en) Preparation of nitro-olefins
IL69385A0 (en) Preparation of 1-azolyl-3,3-dimethyl-1-phenoxybutan-2-ols
GB2121405B (en) Preparation of bischoline naphathalene-disulphonates
DE3262241D1 (en) Process for the preparation of 4,4'-diamino-1,1'-dianthrimides
DE3377217D1 (en) Process for the preparation of monobenzoylated 1,4-diaminoanthraquinones
GB8311446D0 (en) Preparation of 3-hydroxy-benzodiazepinones
IL68545A0 (en) Preparation of cyanohydrincarboxylates